Page 150 - Read Online

Zhao et al. Developments in auxiliary examination of CJD

REFERENCES for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659-68.
19. Zhao W, Zhang JT, Xing XW, Huang DH, Tian CL, Jia WQ, Huang
1. Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, XS, Wu WP, Pu CQ, Lang SY, Yu SY. Chinese specific characteristics
Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre of sporadic Creutzfeldt-Jakob disease: a retrospective analysis of 57
N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta cases. PLoS One 2013;8:e58442.
Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward 20. Schmitz M, Ebert E, Stoeck K, Karch A, Collins S, Calero M,
H, Pocchiari M, van Duijn CM, Will RG, Zerr I. Mortality from Sklaviadis T, Laplanche JL, Golanska E, Baldeiras I, Satoh K,
Creutzfeldt-Jakob disease and related disorders in Europe, Australia, Sanchez-Valle R, Ladogana A, Skinningsrud A, Hammarin AL,
and Canada. Neurology 2005;64:1586-91. Mitrova E, Llorens F, Kim YS, Green A, Zerr I. Validation of 14-3-3
2. Linsell L, Cousens SN, Smith PG, Knight RS, Zeidler M, Stewart G, protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic.
de Silva R, Esmonde TF, Ward HJ, Will RG. A case-control study of Mol Neurobiol 2016;53:2189-99.
sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis 21. Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-
of clustering. Neurology 2004;63:2077-83. Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Challenging
3. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, the clinical utility of the 14-3-3 protein for the diagnosis of sporadic
Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani Creutzfeldt-Jakob disease. Arch Neurol 2003;60:813-6.
A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, 22. Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, Spear C,
Kretzschmar H. Classifiation of sporadic Creutzfeldt-Jakob disease Bizzi A, Debanne SM, Rowland DY. A comparison of tau and 14-
based on molecular and phenotypic analysis of 300 subjects. Ann 3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology
Neurol 1999;46:224-33. 2012;79:547-52.
4. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and 23. Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg
familial CJD: classification and characterisation. Br Med Bull H. Diagnostic performance of cerebrospinal fluid total tau and
2003;66:213-39. phosphorylated tau in Creutzfeldt-Jakob disease: results from the
5. Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda Swedish Mortality Registry. JAMA Neurol 2014;71:476-83.
B, Nanda A. Creutzfeldt-Jakob disease: updated diagnostic criteria, 24. Forner SA, Takada LT, Bettcher BM, Lobach IV, Tartaglia MC,
treatment algorithm, and the utility of brain biopsy. Neurosurg Focus Torres-Chae C, Haman A, Thai J, Vitali P, Neuhaus J, Bostrom A,
2015;39:E2. Miller BL, Rosen HJ, Geschwind MD. Comparing CSF biomarkers
6. Sikorska B, Knight R, Ironside JW, Liberski PP. Creutzfeldt-Jakob and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease.
disease. Adv Exp Med Biol 2012;724:76-90. Neurol Clin Pract 2015;5:116-25.
7. Mead S. Prion disease genetics. Eur J Hum Genet 2006;14:273-81. 25. Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F,
8. Johnson RT. Prion diseases. Lancet Neurol 2005;4:635-42. Müller-Heine A, Zerr I. Cerebrospinal fluid tau levels are a marker for
9. Mastrianni JA. Prion diseases and dementia. In: Power C, Johnson molecular subtype in sporadic Creutzfeldt-Jakob disease. Neurobiol
RT, editors. Emerging neurological infections. Boca Raton: Taylor Aging 2015;36:1964-8.
and Francis; 2005. p. 77-113. 26. Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L,
10. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible Oliveira CR. Diagnostic value of CSF protein profile in a Portuguese
person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J population of sCJD patients. J Neurol 2009;256:1540-50.
Med 1974;290:692-3. 27. Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata
11. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie M, Niwa M, Katamine S, Kurihara S, Matsuo H. 14-3-3 protein, total
J, Will RG. Possible transmission of variant Creutzfeldt-Jakob disease tau and phosphorylated tau in cerebrospinal fluid of patients with
by blood transfusion. Lancet 2004;363:417-21. Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.
12. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related Cell Mol Neurobiol 2006;26:45-52.
transmissible spongiform encephalopathies. N Engl J Med 28. Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven
1998;339:1994-2004. H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen
13. Lee J, Hyeon JW, Kim SY, Hwang KJ, Ju YR, Ryou C. Review: P, Christiansen M. The diagnostic efficiency of biomarkers in
laboratory diagnosis and surveillance of Creutzfeldt-Jakob disease. J sporadic Creutzfeldt-Jakob disease compared to Alzheimer’s disease.
Med Virol 2015;87:175-86. Neurobiol Aging 2009;30:1834-41.
14. Head MW, Ironside JW. Review: Creutzfeldt-Jakob disease: prion 29. Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D,
protein type, disease phenotype and agent strain. Neuropathol Appl Will RG, Knight RS, Green AJ. The role of cerebrospinal fluid 14-3-
Neurobiol 2012;38:296-310. 3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob
15. Broadie K, Rushton E, Skoulakis EM, Davis RL. Leonardo, a disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry
Drosophila 14-3-3 protein involved in learning, regulates presynaptic 2010;81:1243-8.
function. Neuron 1997;2:391-402. 30. World Health Organization. WHO manual for surveillance of human
16. van Hemert MJ, Steensma HY, van Heusden GP. 14-3-3 proteins: transmissible spongiform encephalopathies, including variant
key regulators of cell division, signalling and apoptosis. Bioessays Creutzfeldt-Jakob disease. Geneva, Switzerland: World Health
2001;23:936-46. Organization Communicable Disease Surveillance and Response; 2003.
17. Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner 31. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight
B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt- RS, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado
Jakob disease differ across molecular subtypes. Neurobiol Aging Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz
2009;30:1842-50. Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of
18. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-
U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik Jakob disease. Neurology 2000;55:811-5.
S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, 32. Wieser HG, Schwarz U, Blättler T, Bernoulli C, Sitzler M, Stoeck K,
Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Glatzel M. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-
Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria Jakob disease. Clin Neurophysiol 2004;115:2467-78.
142 Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ July 21, 2017